Y-Intercept (HK)
BNTX icon

Y-Intercept (HK)’s BioNTech BNTX Stock Holding History

Y-Intercept (HK)’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-4,623
Closed -$430K – 1613
2026
Q2 		$430K Buy
+4,623
New +$435K 0.01% 1355
2024
Q4 		– Sell
-6,046
Closed -$718K – 1207
2024
Q3 		$718K Buy
+6,046
New +$556K 0.04% 595
2024
Q1 		– Sell
-11,696
Closed -$1.23M – 1381
2023
Q4 		$1.23M Buy
+11,696
New +$1.18M 0.11% 249
2022
Q4 		– Sell
-4,010
Closed -$541K – 1015
2022
Q3 		$541K Sell
4,010
-26,790
-87% -$4.1M 0.05% 503
2022
Q2 		$4.59M Buy
+30,800
New +$4.71M 0.6% 20
2022
Q1 		– Sell
-1,003
Closed -$259K – 729
2021
Q4 		$259K Sell
1,003
-5,258
-84% -$1.44M 0.06% 439
2021
Q3 		$1.71M Buy
+6,261
New +$1.99M 0.31% 88

Other funds holding BNTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Fideuram - Intesa Sanpaolo Private Banking
Fideuram - Intesa Sanpaolo Private Banking Turin $3.5B AUM 45.13% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
Slow Capital
Slow Capital Greenbrae, California $890M AUM 40.96% 1-Year Est. Return
SGH
Sivik Global Healthcare Greenwich, Connecticut $175M AUM 28.78% 1-Year Est. Return
Crossmark Global Holdings
Crossmark Global Holdings Houston, Texas $7.69B AUM 31.68% 1-Year Est. Return
CCP
Crocodile Capital Partners Ursensollen, Germany $160M AUM 18.68% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
TAA
TB Alternative Assets Grand Cayman, Cayman Islands $488M AUM 102.53% 1-Year Est. Return
PensionDanmark
PensionDanmark Copenhagen O, Denmark $12.3B AUM 33.99% 1-Year Est. Return

Y-Intercept (HK)'s BNTX Position: Q3 2026 in Review

Y-Intercept (HK) sold out of BioNTech (BNTX) in Q3 2026, closing a stake of 4,623 shares — an estimated $430K sold.

Y-Intercept (HK) first reported a position in BNTX in Q3 2021 and held it in 7 quarters. The position peaked at $4.59M in Q2 2022. 39 funds tracked by Wall St. Rank hold BNTX as of Q3 2026.

  • Y-Intercept (HK) reported no remaining BioNTech position as of Q3 2026 after selling out during the quarter.
  • Y-Intercept (HK) sold 4,623 BioNTech shares in Q3 2026, an estimated $430K.
  • Y-Intercept (HK) first reported a position in BioNTech in Q3 2021 and held it in 7 quarters.
  • Y-Intercept (HK)'s BioNTech position peaked at $4.59M in Q2 2022.
  • 39 funds tracked by Wall St. Rank held BioNTech as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.